EXCHANGE AGREEMENTExchange Agreement • March 18th, 2024 • Standard Biotools Inc. • Laboratory analytical instruments • Delaware
This EXCHANGE AGREEMENT (this “Agreement”) is made as of March 18, 2024, by and among (a) Standard BioTools Inc., a Delaware corporation (the “Company”), (b) Casdin Private Growth Equity Fund II, L.P. and Casdin Partners Master Fund, L.P. (collectively, the “Casdin Investors”) and (c) Viking Global Opportunities Illiquid Investments Sub-Master LP and Viking Global Opportunities Drawdown (Aggregator) LP (collectively, the “Viking Investors”). Each of the Casdin Investors and the Viking Investors is referred to herein as an “Investor” and, collectively, the “Investors”.
